1
|
Lopez-Gonzalez JS, Cristerna-Sanchez L, Vazquez-Manriquez ME, Jimenez-Orci G, Aguilar-Cazares D. Localization and Level of Expression of β-Catenin in Human Laryngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2016; 130:89-93. [PMID: 14726916 DOI: 10.1016/j.otohns.2003.09.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE: We studied the participation of β-catenin in the histologic differentiation of laryngeal squamous cell carcinomas. STUDY DESIGN AND SETTING: At the National Institute of Respiratory Diseases, a tertiary referral center, localization and level of expression of β-catenin were compared between normal epithelium (15 cases) and primary tumors in different degrees of differentiation (38 cases), using an immunohistochemical procedure. RESULTS: Cell membrane staining of β-catenin was observed in normal epithelium and in well and moderately differentiated carcinomas. Cytoplasmic redistribution was observed in poorly differentiated carcinomas. Loss of β-catenin correlated with tumor dedifferentiation. CONCLUSION: Reduction of cell membrane β-catenin expression correlated with tumor dedifferentiation. SIGNIFICANCE: Loss of β-catenin may lead to diminishing the strength of the intercellular adhesion system, thereby promoting the invasive phenotype of the squamous cell carcinoma of the larynx.
Collapse
Affiliation(s)
- Jose Sullivan Lopez-Gonzalez
- Departmentos de Enfermedades Cronico Degenerativas, Instituto Nacional de Enfermedades Respiratorias, Mexico City, mexico.
| | | | | | | | | |
Collapse
|
2
|
Costa HO, Neto OM, Eckley CA. Is There a Relationship Between the pH and Volume of Saliva and Esophageal pH-metry Results? Dysphagia 2005; 20:175-81. [PMID: 16362506 DOI: 10.1007/s00455-005-0016-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
There are several implications in the buffer capacity and in the protective role of saliva in gastroesophageal reflux disease (GERD) and other digestive disorders. The lack of knowledge about the production and quality of saliva and the fact that saliva plays an important role in digestive homeostasis motivated the authors to study the relationship between reflux measured by esophageal pH-metry and the pH and volume of saliva in individuals with GERD and its laryngopharyngeal manifestations (LPR). The study was designed as a randomized clinical trial. The studied population consisted of 39 adults with GERD and LPR confirmed by a positive 24-hour double-probe esophageal pH-metry. Unstimulated whole saliva was collected and its pH and volume were compared to pH-metry results. Patients were divided into four groups according to the number of distal episodes of reflux and two groups according to the presence or absence of proximal reflux. A highly significant difference was found between the groups with distal reflux when comparing salivary volume alone and salivary volume/salivary pH. The same occurred for the presence or absence of proximal reflux. These results suggest a direct correlation between salivary volume and "salivary pH x volume" with the number of distal and proximal episodes of reflux on the esophageal pH-metry. If larger studies confirm this finding, in the future it might be possible to diagnose GERD and LPR through a simple "spit test," avoiding more costly and invasive procedures.
Collapse
Affiliation(s)
- Henrique Olival Costa
- Institute of Advanced Sciences in Otolaryngology, Rua Prof. Arthur Ramos, 183, 30. andar CEP, São Paulo, São Paulo 01454-000, Brazil.
| | | | | |
Collapse
|
3
|
Abstract
Apesar do grande entusiasmo despertado pelo avanço dos conceitos definidores do conjunto sintomático denominado refluxo laringofaríngeo (RLF), ainda é muito difícil, para o otorrinolaringologista, estabelecer com segurança se esta síndrome poderá ser considerada no futuro como uma doença semelhante ao refluxo gastroesofágico¹. A nosso ver, os sinais inflamatórios no segmento laringofaríngeo encontrados em alguns pacientes que apresentam phmetria com presença de pH abaixo de 4 na sonda proximal podem ser mimificados por outras situações que agridem a região, não sendo, portanto, patognomônicos de RLF. As condições de fluxo salivar, seu volume, clearence e alterações das condições eletrolíticas da saliva podem influenciar na capacidade de proteção da mucosa regional. OBJETIVO: Este estudo teve como principal objetivo observar a relação entre os sintomas laringofaríngeos de inflamação e o pH e volume salivares. FORMA DE ESTUDO: Observacional coorte com corte transversal. MATERIAL E MÉTODO: Foram estudados 59 sujeitos com idades variando de 24 a 76 anos, com média 50,5 anos, sendo 44 mulheres e 15 homens. Todos os pacientes responderam a questionário sobre sintomas laringofaríngeos e tiveram sua saliva coletada e seu volume e pH mensurados. RESULTADOS: O volume médio de saliva coletado no total de pacientes foi 4,3 ml, com o mínimo de 1,5 e um máximo de 7,5. O pH médio foi de 7,1, se estendendo de 6 a 8. Do total de sintomas apresentados, 31 pacientes apresentaram disfonia, 39 apresentaram pigarro, 2 dispnéia, 24 halitose, 4 caseo, 4 amigdalite de repetição, 6 problemas dento-gengivais, 9 aftas, 6 xerostomia, 12 glossodínia, 36 globus pharingeus, 2 odinofagia, 16 tosse e 8 disfagia. As diversas correlações entre pH, volume salivar e sintomas foram observadas mostrando, em alguns casos, forte correlação positiva ou negativa. CONCLUSÃO: O pH salivar, na dependência do volume salivar, pode ter forte interferência na sintomatologia faringolaríngea.
Collapse
|
4
|
Abstract
OBJECTIVE To review recent advances in our understanding of molecular biology and wound healing relevant to facial plastic surgery. DATA SOURCES Recent basic science literature relevant to molecular biology and wound healing and its clinical implications. CONCLUSIONS During the 21st century, we will experience a new biological and informational age that will have profound implications for facial plastic surgery. This modern era will be driven by discoveries in molecular biology and wound healing that will result in new diagnosis and treatment modalities.
Collapse
Affiliation(s)
- D B Hom
- Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head & Neck Surgery, University of Minnesota School of Medicine, Box 396, 420 Delaware St SE, Minneapolis, MN 55455, USA
| |
Collapse
|
5
|
Contemporary concepts and progress in wound healing. Curr Opin Otolaryngol Head Neck Surg 1999. [DOI: 10.1097/00020840-199908000-00005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register]
|
6
|
Ibrahim SO, Lillehaug JR, Johannessen AC, Liavaag PG, Nilsen R, Vasstrand EN. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncol 1999; 35:302-13. [PMID: 10621852 DOI: 10.1016/s1368-8375(98)00120-1] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Using immunohistochemistry, expression of p53, transforming growth factor-alpha (TGF-alpha), epidermal growth factor receptor (EGFR), c-erbB-2/neu and proliferating cell nuclear antigen (PCNA) was examined in 26 fresh frozen tissue specimens of oropharyngeal squamous cell carcinomas (SCCs). p53 gene mutations were examined by polymerase chain reaction (PCR)/DNA sequencing methods in 22 carcinomas. The findings were examined for correlations with patients' clinicopathological parameters. Expressions of p53 and PCNA were also examined in 21 formalin-fixed corresponding tissues. Of the fresh frozen tissue specimens, 77% (20/26) showed expression and 68% (15/22) showed mutations (substitutions) of the p53, with significant clustering of the mutations in exons 5 (8/22; 36%), 7 (4/22; 18%) and 8 (5/22; 23%). No mutations were found in exon 6. There was a discordance between expression of p53 protein and mutations of the gene. Parallel to expression and mutations of the p53 found in most of the specimens, expression of TGF-alpha, EGFR, c-erbB-2/neu and PCNA was found in 88% (22/25), 92% (23/25), 58% (14/24) and 91% (21/23) of the specimens, respectively. For the formalin-fixed tissue specimens, 62% (13/21) and 90% (19/21) expressed p53 and PCNA, respectively. Examining for correlations with patients' clinicopathological parameters, expression of p53, TGF-alpha, EGFR and c-erB-2/neu seemed to negatively correlate with the increase of the tumour grade. The present work suggests that: (1) lack of negative growth regulation due to inactivation of the p53 gene together with activation of other proto-oncogenes are necessary genetic events in the carcinogenesis of oropharyngeal SCCs; (2) in oropharyngeal SCCs, p53 gene mutations were clustered in exons 5 (codons 130-186), 7 (codons 230-248) and 8 (codons 271-282) which perhaps suggests that tobacco carcinogens probably affect the mutational hot spots of the p53 gene at codons 157, 175, 186, 248, 273 and 282; and (3) fresh frozen and formalin-fixed tissue specimens give similar results when an immunohistochemical method is applied. The importance of p53, TGF-alpha, EGFR, c-erbB-2/neu and PCNA as biomarkers in oropharyngeal SCCs deserves particular attention because it might offer further understanding of the development of these carcinomas.
Collapse
Affiliation(s)
- S O Ibrahim
- Department of Biochemistry and Molecular Biology, University of Bergen, Norway.
| | | | | | | | | | | |
Collapse
|
7
|
He Y, Zeng Q, Drenning SD, Melhem MF, Tweardy DJ, Huang L, Grandis JR. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst 1998; 90:1080-7. [PMID: 9672256 DOI: 10.1093/jnci/90.14.1080] [Citation(s) in RCA: 101] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Squamous cell carcinomas of the head and neck (SCCHN), unlike normal mucosal squamous epithelial cells, overexpress epidermal growth factor receptor (EGFR) messenger RNA and protein. EGFR protein is required to sustain the proliferation of SCCHN cells in vitro. To determine whether EGFR expression contributes to tumor growth, we investigated the effect of suppressing EGFR expression in tumor xenografts through in situ expression of antisense oligonucleotides. METHODS Intratumoral cationic liposome-mediated gene transfer was used to deliver plasmids capable of expressing sense or antisense EGFR sequences into human head and neck tumors, which were grown as subcutaneous xenografts in nude mice. The oligonucleotides were expressed under the control of the U6 RNA promoter. RESULTS Direct inoculation of the EGFR antisense (but not the corresponding sense) plasmid construct into established SCCHN xenografts resulted in inhibition of tumor growth, suppression of EGFR protein expression, and an increased rate of apoptosis (programmed cell death). Sustained antitumor effects were observed for up to 2 weeks after the treatments were discontinued. CONCLUSION These results suggest that interference with EGFR expression, using an antisense-based gene therapy approach, may be an effective means of treating EGFR-overexpressing tumors, including SCCHN.
Collapse
MESH Headings
- Animals
- Carcinoma, Squamous Cell/genetics
- Carcinoma, Squamous Cell/therapy
- ErbB Receptors/biosynthesis
- ErbB Receptors/genetics
- Female
- Gene Expression Regulation, Neoplastic
- Genetic Therapy/methods
- Head and Neck Neoplasms/genetics
- Head and Neck Neoplasms/therapy
- Humans
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Polymerase Chain Reaction
- Promoter Regions, Genetic
- RNA, Antisense/genetics
- RNA, Antisense/therapeutic use
- RNA, Messenger/genetics
- RNA, Neoplasm/genetics
- RNA-Directed DNA Polymerase
- Recombinant Fusion Proteins/genetics
- Ribonucleoprotein, U4-U6 Small Nuclear/genetics
- Transcription, Genetic
Collapse
Affiliation(s)
- Y He
- Department of Pharmacology, University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute, PA, USA
| | | | | | | | | | | | | |
Collapse
|
8
|
Lee CS. Transforming growth factor alpha immunoreactivity in human gallbladder and extrahepatic biliary tract tumours. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 1998; 24:38-42. [PMID: 9542514 DOI: 10.1016/s0748-7983(98)80123-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
AIMS Transforming growth factor alpha (TGF-alpha), a protein structurally similar to epidermal growth factor (EGF), is implicated in the development of many human tumours. This study examines the expression of TGF-alpha in gallbladder and extrahepatic biliary tract tumours in which EGFR expression has been previously shown to be important. METHODS A monoclonal antibody to the TGF-alpha protein was used to investigate the immunohistochemical expression of TGF-alpha in carcinoma of the gallbladder (n = 13), common bile duct (CBD) (n = 6) and ampulla of Vater (n = 8). Tissues from cases of chronic cholecystitis (n = 11), gallbladder dysplasia (n = 3) and adenoma (n = 1), and ampullary carcinoma in situ (CIS) (n = 3) were used as non-malignant controls. These cases were previously studied for EGFR expression. RESULTS TGF-alpha overexpression, defined as intense immunoreactivity in more than two-thirds of cells immunostained for TGF-alpha, was present in most gallbladder carcinomas (n = 10; 77%) but with no significant differences in expression between different tumour grades. None of the cases of gallbladder dysplasia or chronic cholecystitis had strong TGF-alpha expression and this was significantly different from the carcinomas (P = 0.013 and P = 0.0001, respectively; chi 2 test), although a few cases of chronic cholecystitis showed weak (n = 4), moderate (n = 6) or no (n = 1) immunoreactivity. A few ampullary carcinomas (n = 2; 25%) and CIS (n = 1; 33%), and half of the CBD carcinomas (50%) had strong TGF-alpha immunoreactivity. There was correlation between TGF-alpha and EGFR immunoreactivity in the tumour cases (r = 0.70, r2 = 0.49, P = 0.0001; simple regression analysis), although the rate of EGFR immunoreactivity in CBD and ampullary carcinomas was somewhat higher than that of TGF-alpha. However, no statistically significant correlation between TGF-alpha expression with patient survival or tumour recurrence (r = 0.11, r2 = 0.012, P = 0.65; simple regression analysis) was found. CONCLUSIONS Increased TGF-alpha expression occurs more frequently in gallbladder carcinoma than in gallbladder dysplasia, chronic cholecystitis, CBD or ampullary tumour, with no specific relationship to tumour grade, suggesting that TGF-alpha overexpression occurs early in the development of gallbladder cancers, and that biliary tract cancers have a different molecular origin. Correlation was found between TGF-alpha and EFGR expression in gallbladder and biliary tract tumours.
Collapse
Affiliation(s)
- C S Lee
- Department of Pathology, University of Melbourne, Australia
| |
Collapse
|
9
|
Solorzano CC, Jones SC, Pettitjean M, O'Daniel TG, Auffenberg T, Woost PG, Copeland EM, Moldawer LL, Schultz GS, MacKay SL. Inhibition of transforming growth factor alpha stimulation of human squamous cell carcinoma of the head and neck with anti-TGF-alpha antibodies and tyrphostin. Ann Surg Oncol 1997; 4:670-84. [PMID: 9416416 DOI: 10.1007/bf02303753] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND Transforming growth factor alpha (TGF-alpha) and its receptor (EGF-R) may regulate normal and malignant epithelial cell growth by an autocrine mechanism. We investigated the role of TGF-alpha in regulating head and neck SCC tumor growth. METHODS TGF-alpha and EGF-R levels were measured in 7 SCC cell lines and 14 SCC biopsies by RIA, Scatchard, and Western analysis. TGF-alpha autocrine stimulation of DNA synthesis in SCC cell lines was assessed by incubation with TGF-alpha neutralizing antibodies and tyrphostin AG 1478, a selective and potent inhibitor of EGF-R kinase. RESULTS All SCC cell lines synthesized TGF-alpha and expressed elevated EGF-R levels compared to normal keratinocytes. Twelve of the 14 SCC biopsies contained TGF-alpha protein and 8 had specific EGF-R. Exogenous TGF-alpha or EGF significantly increased DNA synthesis in 4 of 5 SCC cell lines. TGF-alpha neutralizing antibodies or tyrphostin AG 1478 reduced DNA synthesis in the two SCC cell lines (FaDu and SCC9) tested. CONCLUSIONS These results indicate that SCC cell lines and tumors usually synthesize TGF-alpha, have elevated levels of EGF-R, and are mitogenically stimulated by a TGF-alpha autocrine system. Selective inhibition of the TGF-alpha system by EGF-R kinase inhibitors or TGF-alpha neutralizing antibodies may be useful strategies for treating SCC that overexpress TGF-alpha and its receptor.
Collapse
Affiliation(s)
- C C Solorzano
- Department of Biochemistry, University of Louisville, Kentucky, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Levin RJ, Wu Y, McLaughlin PJ, Zagon IS. Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma. Laryngoscope 1997; 107:335-9. [PMID: 9121309 DOI: 10.1097/00005537-199703000-00011] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Despite the prevalence of cancers of the head and neck, survival rates have not changed in the past few decades. Recent work has implicated peptide growth factors and their receptors in the genesis and progression of head and neck squamous cell carcinoma. Opioid growth factor (OGF, [Met5]-enkephalin) is a tonically active, autocrine and/or paracrine produced, inhibitory factor that influences the growth of normal and abnormal cells and tissues. This peptide interacts with the zeta (zeta) opioid receptor to modulate cellular proliferation, migration, and survival. Both OGF and the zeta receptor are present in mammalian tongue epithelium and skin, and modulate DNA synthesis. In the present study we examined the presence and distribution of OGF and the zeta opioid receptor in the head and neck squamous cell carcinomas from seven individuals. All specimens expressed this growth factor and its receptor regardless of tumor stage, location, and histologic grade. Immunoreactivity for both OGF and the zeta receptor were associated with the cytoplasm but not the nucleus in cells of each of these carcinomas. Our findings that a potent negative growth regulator and its receptor are present in head and neck squamous cell carcinoma lead us to suggest that OGF may modulate the growth of these types of cancers.
Collapse
MESH Headings
- Aged
- Carcinoma, Squamous Cell/genetics
- Carcinoma, Squamous Cell/pathology
- Cell Division
- Cell Movement
- Cell Nucleus/ultrastructure
- Cell Survival
- Cytoplasm/ultrastructure
- DNA/biosynthesis
- Disease Progression
- Enkephalin, Methionine/analysis
- Enkephalin, Methionine/genetics
- Enkephalin, Methionine/physiology
- Epithelium/pathology
- Female
- Fluorescent Antibody Technique, Direct
- Gene Expression Regulation, Neoplastic
- Head and Neck Neoplasms/genetics
- Head and Neck Neoplasms/pathology
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Neoplasm Staging
- Prevalence
- Receptors, Opioid/analysis
- Receptors, Opioid/genetics
- Receptors, Opioid/physiology
- Skin/pathology
- Survival Rate
- Tongue/pathology
Collapse
Affiliation(s)
- R J Levin
- Division of Otolaryngology/Head and Neck Surgery, The Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, Hershey 17033, U.S.A
| | | | | | | |
Collapse
|
11
|
Lee CS, Redshaw A, Boag G. TGF-alpha immunoreactivity in laryngeal carcinoma: lack of prognostic value and correlation to EGF-receptor expression. THE AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY 1996; 66:464-8. [PMID: 8678876 DOI: 10.1111/j.1445-2197.1996.tb00783.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
BACKGROUND Transforming growth factor alpha (TGF-alpha) is a polypeptide that is structurally similar to epidermal growth factor (EGF) that binds to the epidermal growth factor receptor (EGFR) and has been implicated in the development of several types of human tumours. METHODS The expression of TGF-alpha is examined in laryngeal squamous cell carcinoma (SCC) (n = 24) and non-neoplastic polyps (n = 7) using streptavidin-biotin immunohistochemistry and a monoclonal antibody to the TGF-alpha protein. These cases had been previously characterized for EGFR immunoreactivity. The carcinomas were classified as well differentiated (n = 2), moderately differentiated (n = 16) and poorly differentiated (n = 6). Tissues from metastatic tumour deposits in lymph nodes (n = 5) were also studied. RESULTS TGF-alpha overexpression was defined as intense immunoreactivity in more than two-thirds of tumour cells immunostained for TGF-alpha and was present in the majority of the SCC cases (n = 15; 63%) and metastatic tumour deposits (n = 4; 80%). In contrast, although some of the vocal cord polyps showed weak (n = 2) to moderate (n = 5) immunostaining, none had evidence of strong TGF-alpha immunoreactivity. The differences in TGF-alpha immunoreactivity were significant between primary laryngeal SCC and vocal cord polyps (P = 0.013; chi 2 test with continuity correction), and between metastatic laryngeal SCC and vocal cord polyps (P = 0.023; chi 2 test with continuity correction). There was no significant difference in TGF-alpha expression between the different grades of carcinomas (P = 0.92, chi 2 test) or between non-metastatic and metastatic carcinomas (P = 0.82; chi 2 test with continuity correction). No significant correlation was found between TGF-alpha expression and patient survival or tumour recurrence (r = 0.077, r2 = 0.006, P = 0.75; simple regression analysis), or between TGF-alpha expression and EGFR immunoreactivity (r = 0.325, r2 = 0.106, P = 0.0851). CONCLUSIONS In conclusion, increased TGF-alpha immunoreactivity is present in most cases of laryngeal SCC with no specific relationship to tumour grade, suggesting that it may be important in the development of laryngeal carcinomas but not in its progression. No significant correlation was found between TGF-alpha and EGFR expression in laryngeal tumours and TGF-alpha immunoreactivity is of no prognostic value.
Collapse
Affiliation(s)
- C S Lee
- Department of Pathology, University of Melbourne, St George Hospital, Kogarah, New South Wales, Australia
| | | | | |
Collapse
|
12
|
Wen QH, Miwa T, Yoshizaki T, Nagayama I, Furukawa M, Nishijima H. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope 1996; 106:884-8. [PMID: 8667988 DOI: 10.1097/00005537-199607000-00019] [Citation(s) in RCA: 65] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The purpose of this study was to determine the overexpression of both epidermal growth factor receptor (EGFR) and transforming growth factor-alpha (TGF-alpha) (a ligand of EGFR) in early laryngeal squamous cell carcinoma. In addition, we attempted to evaluate the prognostic values of our findings. Expression of EGFR and TGF-alpha in tumor tissue was examined immunohistochemically in 68 patients who had been treated with radiotherapy for early laryngeal cancer. Overexpression of the two factors was noted in 42.6% and 55.9%, respectively. No significant differences due to age, tumor size, and location or grade of cancer tissues were seen. Higher survival rates, found in patients with EGFR (-) and TGF-alpha (-) tumors as compared with those with EGFR (+) and TGF-alpha (+) (97.4%, 100% and 86.2%, 86.8%, respectively), were not statistically significant. The recurrence rates were similar between EGFR (+) and EGFR (-) (37.9% and 35.9%, respectively). However, the recurrence rate in patients with TGF-alpha (+) was significantly higher (57.9%) than in those with TGF-alpha (-) (10%; P<.01). Therefore overexpression of TGF-alpha may be an important indicator for recurrence in patients with early laryngeal squamous cell carcinoma treated by irradiation.
Collapse
Affiliation(s)
- Q H Wen
- Department of Oto-Laryngology, School of Medicine, Kanazawa University, Ishikawa, Japan
| | | | | | | | | | | |
Collapse
|
13
|
Bergler W, Petroianu G, Juncker C, Hörmann K. Correlation of transforming growth factor alpha and epidermal growth factor receptor in oropharyngeal carcinomas. Acta Otolaryngol 1996; 116:486-9. [PMID: 8790752 DOI: 10.3109/00016489609137877] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Previous studies have shown increasing evidence that TGF-alpha, a ligand for the often overexpressed EGF-receptor may be important for the oncogenesis and autocrine stimulation of the proliferation in head and neck cancers. The occurrence of TGF-alpha and its relation to the EGF-receptor still remain unclear. Twenty six specimens (primaries and metastasis) of oropharyngeal squamous cell carcinomas were investigated for the presence of transforming growth factor alpha (TGF-alpha), epidermal growth factor (EGF) and the EGF-receptor using a tissue extraction method and a "sandwich" immuno absorbent assay. In 77% of the specimens we found TGF-alpha, all had a significant amount of EGF-receptors, no EGF was found. No significant difference was noted for metastasis and primaries. No correlation was seen to the TNM stage and to the histological grading. There was an inverse statistical correlation between the TGF-alpha and the EGF-receptor concentration. High TGF-alpha concentrations were associated with low EGF-receptor concentration. Interestingly, even high TGF-alpha concentrations showed a lower limit of EGF-receptor concentrations which could not be passed. The present investigation gives a quantitative determination of the EGF-receptors and TGF-alpha in oropharyngeal carcinomas. The results indicate that a EGF-receptor/TGF-alpha complex could be functionally important for autocrine/paracrine stimulation.
Collapse
Affiliation(s)
- W Bergler
- Department of Otorhinolaryngology, Faculty of Clinical Medicine Mannheim, Germany
| | | | | | | |
Collapse
|
14
|
|